263 related articles for article (PubMed ID: 18484237)
1. The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis.
Siepman TA; Janssens AC; de Koning I; Polman CH; Boringa JB; Hintzen RQ
J Neurol; 2008 Jun; 255(6):910-6. PubMed ID: 18484237
[TBL] [Abstract][Full Text] [Related]
2. The relationship of cognitive impairment with neurological and psychiatric variables in multiple sclerosis patients.
Karadayi H; Arisoy O; Altunrende B; Boztas MH; Sercan M
Int J Psychiatry Clin Pract; 2014 Jan; 18(1):45-51. PubMed ID: 24047424
[TBL] [Abstract][Full Text] [Related]
3. Depressive Symptoms Are Associated With More Negative Functional Outcomes Than Anxiety Symptoms in Persons With Multiple Sclerosis.
Gill S; Santo J; Blair M; Morrow SA
J Neuropsychiatry Clin Neurosci; 2019; 31(1):37-42. PubMed ID: 30187820
[TBL] [Abstract][Full Text] [Related]
4. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
López-Góngora M; Querol L; Escartín A
BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
[TBL] [Abstract][Full Text] [Related]
5. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
[TBL] [Abstract][Full Text] [Related]
6. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
[TBL] [Abstract][Full Text] [Related]
7. Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis.
Sonder JM; Burggraaff J; Knol DL; Polman CH; Uitdehaag BM
Mult Scler; 2014 Apr; 20(4):481-8. PubMed ID: 24019305
[TBL] [Abstract][Full Text] [Related]
8. Walking and cognition, but not symptoms, correlate with dual task cost of walking in multiple sclerosis.
Motl RW; Sosnoff JJ; Dlugonski D; Pilutti LA; Klaren R; Sandroff BM
Gait Posture; 2014 Mar; 39(3):870-4. PubMed ID: 24378281
[TBL] [Abstract][Full Text] [Related]
9. The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population.
Amato MP; Portaccio E; Goretti B; Zipoli V; Ricchiuti L; De Caro MF; Patti F; Vecchio R; Sorbi S; Trojano M
Mult Scler; 2006 Dec; 12(6):787-93. PubMed ID: 17263008
[TBL] [Abstract][Full Text] [Related]
10. Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort.
Amato MP; Zipoli V; Goretti B; Portaccio E; De Caro MF; Ricchiuti L; Siracusa G; Masini M; Sorbi S; Trojano M
J Neurol; 2006 Aug; 253(8):1054-9. PubMed ID: 16609810
[TBL] [Abstract][Full Text] [Related]
11. Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis.
Amezcua L; Smith JB; Gonzales EG; Haraszti S; Langer-Gould A
Neurology; 2020 Apr; 94(14):e1548-e1556. PubMed ID: 32152131
[TBL] [Abstract][Full Text] [Related]
12. Anxiety and depressive symptoms in caregivers of multiple sclerosis patients: The role of information processing speed impairment.
Labiano-Fontcuberta A; Mitchell AJ; Moreno-García S; Benito-León J
J Neurol Sci; 2015 Feb; 349(1-2):220-5. PubMed ID: 25638658
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool.
Yoshii F; Takagi S; Nagata E; Hasegawa Y; Kunika N; Maki F; Mochizuki H; Ogino M; Kuroiwa Y
J Neurol Sci; 2015 Dec; 359(1-2):323-7. PubMed ID: 26671136
[TBL] [Abstract][Full Text] [Related]
14. Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis.
Janssens AC; van Doorn PA; de Boer JB; Kalkers NF; van der Meche FG; Passchier J; Hintzen RQ
Mult Scler; 2003 Aug; 9(4):397-403. PubMed ID: 12926846
[TBL] [Abstract][Full Text] [Related]
15. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Siracusa G; Sorbi S; Amato MP
Clin Neuropsychol; 2009 Feb; 23(2):268-75. PubMed ID: 18609336
[TBL] [Abstract][Full Text] [Related]
16. Quality of Life, Cognition and Mood in Adults with Pediatric Multiple Sclerosis.
Krysko KM; O'Connor P
Can J Neurol Sci; 2016 May; 43(3):368-74. PubMed ID: 26795374
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment in different MS subtypes and clinically isolated syndromes.
Potagas C; Giogkaraki E; Koutsis G; Mandellos D; Tsirempolou E; Sfagos C; Vassilopoulos D
J Neurol Sci; 2008 Apr; 267(1-2):100-6. PubMed ID: 17997417
[TBL] [Abstract][Full Text] [Related]
18. The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
Dackovic J; Pekmezovic T; Mesaros S; Dujmovic I; Stojsavljevic N; Martinovic V; Drulovic J
Neurol Sci; 2016 Sep; 37(9):1475-81. PubMed ID: 27207679
[TBL] [Abstract][Full Text] [Related]
19. Impairment of daily occupations in multiple sclerosis: analysis of neuroimaging, general and social cognition, and reserve.
Gomes LR; Damasceno BP; de Campos BM; Damasceno A
Mult Scler Relat Disord; 2024 Jan; 81():105140. PubMed ID: 37988860
[TBL] [Abstract][Full Text] [Related]
20. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
Edgar C; Jongen PJ; Sanders E; Sindic C; Goffette S; Dupuis M; Jacquerye P; Guillaume D; Reznik R; Wesnes K
BMC Neurol; 2011 Jun; 11():68. PubMed ID: 21649910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
